For most of the last fifty years, medicine has sorted post-traumatic stress disorder and traumatic brain injury into separate files. A psychiatrist handled the first; a neurologist handled the second. The sorting felt rational because the visible causes differed — something frightening happened in PTSD; something physical happened to the head in TBI. Two distinct mechanisms, two distinct treatment paths, two different specialists.

The problem is that both mechanisms often occur in the same person. Military personnel exposed to blast injuries. Survivors of automobile collisions. People who have experienced physical forms of violence. In these populations, what lands on the head can also leave a psychological mark, and psychological trauma can arrive alongside physical impact. When clinicians started looking at this overlap more carefully, they found it in brain imaging too — not just the same risk factors, but the same neural real estate.

What 2026 research has been asking is whether those shared circuits look the same under both conditions, or whether they leave distinct signatures. The answer, it turns out, is both.

The Logic That Separated Two Diagnoses

The clinical separation of PTSD and traumatic brain injury has real foundations. PTSD is organized around the fear memory network. The amygdala encodes the threat. The ventromedial prefrontal cortex — the vmPFC — normally regulates the amygdala’s response, keeping fear reactions calibrated to actual danger. In PTSD, this regulatory pathway appears to be disrupted: the amygdala responds as though the threat is ongoing; the vmPFC fails to provide adequate inhibition. The result is a system that cannot locate the threat in the past.

Mild traumatic brain injury operates through a different mechanism. Concussion involves mechanical stress to brain tissue: shearing of axons, disruption of white matter tracts, diffuse neuroinflammation. The Glasgow Coma Scale, the cognitive screening battery, the structural MRI — these tools were developed to detect and characterize physical damage to the organ itself. The symptoms of mTBI (headaches, cognitive slowing, irritability, difficulty concentrating) were understood as downstream effects of that physical damage.

For a long time, the populations in question barely overlapped. The person who survived a car accident and was concussed was different from the person who witnessed violence. The framework held.

It started to strain when it encountered populations where both mechanisms were common at once. Veterans of conflicts involving improvised explosive devices often sustained blast exposures that were simultaneously physically jarring and psychologically traumatizing. Motor vehicle collision survivors regularly presented with both cognitive post-concussive symptoms and fear-based trauma responses. In these populations, asking which condition was causing which symptoms became clinically complicated — and the brain imaging, when researchers started looking at it, began to tell a more complicated story as well.

What Frontolimbic Imaging Finds When Both Are Present

A 2026 study published in Brain Communications took a transdiagnostic approach to mapping the neural correlates of PTSD symptoms and mTBI symptoms in the same group of veterans (Claar RD, Lamb DG; Brain Communications, 2026). The study followed 109 combat veterans — rather than dividing participants into a PTSD group versus a TBI group, it treated each condition as a continuous symptom dimension and asked which patterns of neural connectivity tracked which symptoms. This is a meaningful methodological difference: it allowed the researchers to look at both overlap and divergence within the same brains, at the same time.

What they found was this: PTSD symptom severity was associated with increased functional connectivity between the right amygdala and the ventromedial prefrontal cortex (P-FDR = 0.0134). That is the regulatory circuit the existing literature had already implicated in PTSD — the same amygdala-vmPFC axis that disrupted fear regulation theory predicts should be altered. mTBI symptom severity, measured independently, was associated with increased connectivity between the right insula and the right supramarginal gyrus (P-FDR = 0.0348). A different circuit, in a different part of the brain — one associated with the body’s internal state monitoring and sensorimotor integration.

The two circuits are related: both involve regions that process emotionally salient information. But they are not the same circuit. PTSD and mTBI are not producing identical neuroimaging signatures in these veterans. They are producing overlapping but distinct signatures, in systems that serve different functions.

No significant group-by-symptom interaction survived multiple comparison correction, which suggests the two circuits are operating at least partly independently, rather than one driving the other. In a population where both conditions are common, this matters: it means each condition may need to be understood and addressed on its own terms, not assumed to follow from the other.

A Concussion Changes How the Brain Responds to Fear

The separation between circuits does not mean PTSD and concussion are unrelated in their moment-to-moment effects. A 2026 study published in Brain Sciences examined what happens when fearful stimuli are presented to people who had both PTSD symptoms and a concurrent mTBI, compared to those with PTSD symptoms alone, in the weeks immediately following a motor vehicle collision (Wu J et al.; Brain Sciences, 2026).

The study was small — groups ranging from five to twelve participants — and its findings need to be interpreted cautiously and replicated before they can be treated as reliable generalizations. But what it measured is specific: the anterior insula cortex activation during the appraisal of fearful stimuli, assessed at two weeks post-collision. At that time point, individuals with both mTBI and probable PTSD showed anterior insula activation significantly greater than those with PTSD symptoms alone (mean activation 0.125 vs. 0.014). The difference was not subtle.

The anterior insula is a region involved in interoception — the body’s ongoing sense of its own internal state — and in the early detection of salient, potentially threatening information. It sits within the network that Claar and Lamb identified as associated with mTBI symptoms: the insula-supramarginal system. What the Wu study suggests is that in the acute phase after a combined physical-psychological trauma event, the brain may be responding to fear differently when there was a concurrent concussion — the region that processes the internal sensory experience of threat responding more strongly than when the psychological trauma occurred alone.

Whether this acute hyperactivation resolves over time, and whether it corresponds to the persistent mTBI-associated connectivity changes found in veterans, are questions the current data cannot answer. What it raises is the possibility that a concurrent mTBI alters the early trajectory of how the brain begins to process traumatic experience.

The Brain Over Time: What Happens When Both Conditions Persist

What happens to a brain that has been exposed to both PTSD and concussion, over months and years? A 2026 longitudinal study examined this in 79 veterans, following them across three assessment points over 18 months (Klaming R et al.; NeuroImage Reports, 2026). The researchers used brain age prediction — an approach that estimates how old the brain appears structurally, relative to what would be expected for a person of that chronological age.

At baseline, the veterans’ brains appeared an average of 4.8 years older than their chronological age. Over 18 months, this gap widened to 6.5 years. A brain that appears structurally older than its owner’s calendar age, in the absence of major neurodegenerative disease, is one that has experienced accumulating biological change.

One finding from this study is particularly notable — and not easy to interpret. The accelerated brain aging was not correlated with symptom severity. Veterans with more severe symptoms were not necessarily those whose brains were aging faster. The brain-level changes and the symptom experience were tracking different things. This does not make either finding less real; it suggests they reflect different aspects of the same underlying biology, running on somewhat separate timelines. It also means that inferring someone’s biological brain state from their symptoms — or assuming the absence of symptoms means the brain is unaffected — would be a mistake.

A complementary analysis by Sibilia and colleagues, using a large multimodal imaging dataset of war veterans, found that both PTSD history and TBI history were associated with worse cognitive outcomes (Sibilia F et al.; Journal of Alzheimer’s Disease, 2026). Importantly, neither was strongly associated with the amyloid, tau, or vascular neuroimaging markers more characteristic of late-life neurodegenerative conditions. The brain changes being captured appear to be distinct from standard aging or dementia pathology. They represent something more specific to the combined exposure itself.

Reading the Same Circuits from the Other Direction

One way to test what a neural circuit actually does is to try to change it and observe what follows. A 2026 study took a computational approach to this question for PTSD specifically: using resting-state fMRI data from 350 veterans with and without PTSD, researchers built a model to predict where cortical stimulation would change functional connectivity, and linked those predicted changes to symptom severity (Chandrashekar S et al.; Biological Psychiatry: Global Open Science, 2026).

The model identified two broad patterns. Stimulation predicted to increase connectivity in the left prefrontal cortex was associated with predicted symptom reduction. Stimulation predicted to decrease connectivity in bilateral parietal and occipital regions was also associated with predicted symptom reduction. These findings map onto what connectivity studies have shown: the prefrontal cortex — and specifically the vmPFC and its regulatory role over the amygdala — is a key node in the PTSD symptom circuit. Its dysfunction is not just theoretical; the model suggests it is an active target whose modification is associated with symptom change.

This study was conducted in a PTSD population, not a combined PTSD-mTBI population. Its direct relevance to the overlap question is limited. But it contributes to a broader picture: the circuits implicated in PTSD symptoms are measurable, respond to perturbation, and that response predicts symptom change at a population level. Whether the same framework will prove applicable to the insula-supramarginal circuit identified as associated with mTBI in the Claar and Lamb study is not yet known — the TBI side of this question is less developed in terms of circuit-level intervention research. But the frontolimbic system, across all five of these 2026 studies, is not a passive correlate of distress. It is active, dynamic, and measurable.

What the Research Does Not Establish

Several important limitations apply to the evidence reviewed here.

The most significant is sample size. The Claar and Lamb study had 109 participants — meaningful for a neuroimaging study, but not a population-scale sample. The Wu study, which examined acute effects after motor vehicle collision, had groups of five to twelve participants. Findings from that size of sample are preliminary and require independent replication before they can be generalized. The direction of an effect measured in twelve people may be real; its magnitude should not be treated as definitive.

The populations studied are not representative of everyone who carries symptoms associated with traumatic stress or who has experienced a head injury. Most participants across these studies were combat veterans — a group with specific exposures, training, healthcare access, and demographic characteristics that differ from civilian populations. Motor vehicle collisions involve different mechanisms than blast exposure. Childhood trauma, domestic violence, and sports-related concussions each have different developmental and physiological contexts. The circuits being measured may behave differently across these populations, and it would be premature to assume the findings apply uniformly.

The brain aging finding from the Klaming study presents its own interpretive challenge. An accelerated brain age gap that is not correlated with symptom severity is a notable dissociation — but the study cannot determine whether the accelerated aging preceded the symptoms, followed them, ran independently, or reflects a confound the study was not designed to measure. The 18-month observation window is too short to establish long-term trajectories.

Finally, all of these studies measure what is happening in groups of people at the level of brain imaging. Population-level connectivity differences do not allow prediction of any individual’s experience. Two people with identical diagnoses and similar trauma histories may show entirely different neuroimaging patterns, and the presence of a pattern in a group study says nothing about whether it is present in a given person. These findings are meaningful for understanding biology and for shaping research questions. They are not clinical tools for individual assessment.